Shots:
HighLife received CE Mark approval for its HighLife Clarity Mitral Heart Valve for use with HighLife TMVR System for adults with symptomatic mod. to sev. or sev. mitral valve regurgitation (MR) who are unsuitable for surgery or transcatheter edge-to-edge repair
Four-year follow-up of the first 35 consecutively treated pts showed durable valve performance, with…
Shots:
Did you know that coronary stent usage can decline by 20 percent if GLP-1 therapy is used as widely as statin therapy?
PharmaShots welcomes Saif Rathore, Founder of Sandbar Life Sciences and Entrepreneur-in-Residence at Yale Ventures, and Andrew Epstein, Principal at Medicus Economics, for an illuminating dialogue exchange
Saif and Andrew highlight the untapped…

